OTCMKTS:CBSC

CB Scientific (CBSC) Stock Forecast, Price & News

$0.17

+0.00 (+2.48%)

(As of 05/20/2022 02:14 PM ET)

Add

Compare

Today's Range: $0.17
▼
$0.18
50-Day Range: $0.15
▼
$0.45
52-Week Range: $0.10
▼
$0.95

Volume: 114,100 shs
Average Volume: 19,130 shs
Market Capitalization: $18.52 million

P/E Ratio: N/A
Dividend Yield: N/A
Beta: 3.14

30 days | 90 days | 365 days | Advanced Chart

Receive CBSC News and Ratings via Email

Sign-up to receive the latest news and ratings for CB Scientific and its competitors with MarketBeat's FREE daily newsletter.

About CB Scientific

CB Scientific, Inc. provides products and services in the ambulatory non-invasive cardiac monitoring space. The company's FDA and CE cleared EKG devices, interactive cloud-based acquisition software, and smartphone apps for both iOS and Android platforms, offers compliance for patients at risk of abnormal heart rhythms and information for physicians. CB Scientific, Inc. is based in Escondido, California.

May 14, 2022 | finance.yahoo.com

CB Scientific, Inc. (CBSC)

April 25, 2022 | tmcnet.com

CB Therapeutics rapidly expands cellular agriculture capabilities at new facility

April 6, 2022 | finanznachrichten.de

CB Scientific, Inc. Announces Uplist to the OTCQB Venture Market

April 6, 2022 | finance.yahoo.com

CB Scientific, Inc. Announces Uplist to the OTCQB(R) Venture Market

March 15, 2022 | finance.yahoo.com

CB Scientific, Inc. Concludes its Annual Audit with MaloneBailey, LLP

March 12, 2022 | msn.com

CBSE Class 12 Term 1 Results Expected Today at cbseresults.nic.in. Steps to Check Scores Here

February 25, 2022 | msn.com

CBSE term 1 result 2022 awaited at cbseresults.nic.in, here's how to check score

January 21, 2022 | msn.com

CBSE Term 1 Results 2021: Class 10, 12 Scores Expected on THIS DATE at cbseresults.nic.in | LIVE Updates

January 18, 2022 | finance.yahoo.com

CB Scientific, Inc. Concludes Its Special Meeting of Stockholders

January 18, 2022 | finance.yahoo.com

CB Scientific, Inc. Concludes Its Special Meeting of Stockholders

January 18, 2022 | msn.com

CBSE Term 1 Result 2021 LIVE News And Updates: Board to Declare Class 10, 12 Scores Anytime Soon at cbseresults.nic.in

January 17, 2022 | msn.com

CBSE releases Class 10, 12 term 2 sample papers on cbseresults.nic.in, direct link to download here

January 16, 2022 | msn.com

CBSE Class 10, 12 Term 1 Results 2021-22 ??expected soon on cbseresults.nic.in, details here

See More Headlines

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Industry: N/A
Sub-Industry: N/A
Sector: Medical
Current Symbol: OTCMKTS:CBSC
Previous Symbol
CUSIP: N/A
CIK: N/A
Web: corp.cbscientific.com
Phone: (888) 225-0870
Fax: N/A
Employees: 5
Year Founded: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Price-To-Earnings

Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A

Miscellaneous

Outstanding Shares: 112,238,000
Free Float: N/A
Market Cap: $18.52 million
Optionable: Not Optionable

Company Calendar

Today: 5/23/2022
Fiscal Year End: 12/31/2022

MarketRank^™

Overall MarketRank^™

0.00 out of 5 stars

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for CB Scientific.

0.0 Community Rank

Outperform Votes
CB Scientific has received 0 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
CB Scientific has received 0 “underperform” votes. (Add your “underperform” vote.)

MarketBeat's community ratings are surveys of what our community members think about CB Scientific and other stocks. Vote “Outperform” if you believe CBSC will outperform the S&P 500 over the long term. Vote “Underperform” if you believe CBSC will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
CB Scientific does not currently pay a dividend.
Dividend Growth
CB Scientific does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, CB Scientific insiders have not sold or bought any company stock.

0.0 Earnings and Valuation

See Top Rated MarketRank™ Stocks Here

CB Scientific (OTCMKTS:CBSC) Frequently Asked Questions

Who are CB Scientific's key executives?: CB Scientific's management team includes the following people:
Mr. Cameron Cox, Chief Operating Officer (Age 48)
Mr. Charles K. Martin III, Pres, CEO & Director (Age 66)
Ms. Brooke Martellaro, Chief Financial Officer
Who are some of CB Scientific's key competitors?: Some companies that are related to CB Scientific include Enlivex Therapeutics (ENLV), Kazia Therapeutics (KZIA), IsoPlexis (ISO), Vigil Neuroscience (VIGL), MDxHealth (MXDHF), Oncology Pharma (ONPH), Pyxis Oncology (PYXS), Curis (CRIS), TScan Therapeutics (TCRX), Spectral Medical (EDT), Genprex (GNPX), Codiak BioSciences (CDAK), Devonian Health Group (GSD), Magenta Therapeutics (MGTA) and BioVie (BIVI).
View all of CBSC's competitors.
What is CB Scientific's stock symbol?: CB Scientific trades on the OTCMKTS under the ticker symbol "CBSC."
How do I buy shares of CB Scientific?: Shares of CBSC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is CB Scientific's stock price today?: One share of CBSC stock can currently be purchased for approximately $0.17.
How much money does CB Scientific make?: CB Scientific has a market capitalization of $18.52 million.
How many employees does CB Scientific have?: CB Scientific employs 5 workers across the globe.
What is CB Scientific's official website?: The official website for CB Scientific is corp.cbscientific.com.
How can I contact CB Scientific?: The company can be reached via phone at (888) 225-0870.

This page was last updated on 5/23/2022 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms

Your Ultimate Investing Toolkit

Just $1.00 for your first month.